Impact of prostate radiotherapy on survival outcomes in clinically node-positive prostate cancer: A multicentre retrospective analysis

医学 前列腺癌 放射治疗 多西紫杉醇 雄激素剥夺疗法 阶段(地层学) 肿瘤科 比例危险模型 前列腺 内科学 泌尿科 癌症 古生物学 生物
作者
Thiraviyam Elumalai,Priyamvada Maitre,Robin Portner,Neethu Billy Graham Mariam,Tom Young,Simon Hughes,Kanchana Wickramasinghe,Rajanee Bhana,Muhammad Farooq Sabar,K. Thippu Jayaprakash,Hitesh Mistry,Peter Hoskin,Ananya Choudhury
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:186: 109746-109746
标识
DOI:10.1016/j.radonc.2023.109746
摘要

Purpose To evaluate clinical outcomes for cN1M0 prostate cancer treated with varied modalities. Materials and methods Men with radiological stage cN1M0 prostate cancer on conventional imaging, treated from 2011-2019 with various modalities across four centres in the UK were included. Demographics, tumour grade and stage, and treatment details were collected. Biochemical and radiological progression-free survival (bPFS, rPFS) and overall survival (OS) were estimated using Kaplan Meier analyses. Potential factors impacting survival were tested with univariable log-rank test and multivariable Cox-proportional hazards model. Results Total 337 men with cN1M0 prostate cancer were included, 47% having Gleason grade group 5 disease. Treatment modalities included androgen deprivation therapy (ADT) in 98.9% men, either alone (19%) or in combinations including prostate radiotherapy (70%), pelvic nodal radiotherapy (38%), docetaxel (22%), or surgery (7%). At median follow up of 50 months, 5-year bPFS, rPFS, and OS were 62.7%, 71.0%, and 75.8% respectively. Prostate radiotherapy was associated with significantly higher bPFS (74.1% vs 34.2%), rPFS (80.7% vs 44.3%) and OS (86.7% vs 56.2%) at five years (log rank p < 0.001 each). On multivariable analysis including age, Gleason grade group, tumour stage, ADT duration, docetaxel, and nodal radiotherapy, benefit of prostate radiotherapy persisted for bPFS [HR 0.33 (95% CI 0.18–0.62)], rPFS [HR 0.25 (0.12–0.51)], and OS [HR 0.27 (0.13–0.58)] (p < 0.001 each). Impact of nodal radiotherapy or docetaxel was not established due to small subgroups. Conclusion Addition of prostate radiotherapy to ADT in cN1M0 prostate cancer yielded improved disease control and overall survival independent of other tumour and treatment factors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健应助一定行采纳,获得10
1秒前
1秒前
1秒前
2秒前
2秒前
Orange应助张钦奎采纳,获得10
2秒前
5秒前
多晶1完成签到,获得积分10
5秒前
6秒前
xingxingxing发布了新的文献求助10
6秒前
7秒前
10秒前
SciGPT应助q792309106采纳,获得10
10秒前
11秒前
上官若男应助卖萌的秋田采纳,获得10
11秒前
袁超发布了新的文献求助30
12秒前
张雯思发布了新的文献求助10
12秒前
JJ发布了新的文献求助10
12秒前
旧梦完成签到 ,获得积分10
13秒前
tramp应助xiamu采纳,获得20
14秒前
xingxingxing完成签到,获得积分10
15秒前
甜甜的悲发布了新的文献求助10
15秒前
量子星尘发布了新的文献求助10
15秒前
张钦奎发布了新的文献求助10
16秒前
16秒前
zhjg发布了新的文献求助10
17秒前
阿超完成签到,获得积分10
17秒前
FashionBoy应助凪凪采纳,获得10
19秒前
19秒前
wanci应助jinzhen采纳,获得10
20秒前
13发布了新的文献求助10
20秒前
小蘑菇应助甜甜的悲采纳,获得10
22秒前
GL发布了新的文献求助10
23秒前
袁超完成签到,获得积分10
23秒前
23秒前
忧郁盼夏发布了新的文献求助10
24秒前
24秒前
q792309106完成签到,获得积分10
25秒前
乖猫要努力应助郭小宝采纳,获得20
25秒前
q792309106发布了新的文献求助10
29秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989334
求助须知:如何正确求助?哪些是违规求助? 3531428
关于积分的说明 11253936
捐赠科研通 3270119
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173